Chartwell Investment Partners, LLC Eli Lilly & CO Transaction History

Chartwell Investment Partners, LLC

$2.89 Billion
Q1 2024

A detailed history of Chartwell Investment Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Chartwell Investment Partners, LLC holds 33,125 shares of LLY stock, worth $30.4 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares

33,125

Previous 36,239 8.59%

Holding current value

$30.4 Million

Previous $21.1 Million 21.99%

% of portfolio

0.89%

Previous 0.74%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $1.84 Million - $2.47 Million	-3,114 Reduced 8.59%	33,125 $25.8 Million
Q4 2023 Feb 15, 2024	BUY	$525.19 - $619.13 $1.95 Million - $2.3 Million	3,709 Added 11.4%	36,239 $21.1 Million
Q3 2023 Nov 07, 2023	BUY	$434.7 - $599.3 $1.15 Million - $1.59 Million	2,649 Added 8.87%	32,530 $17.5 Million
Q2 2023 Jul 25, 2023	SELL	$350.74 - $468.98 $1.16 Million - $1.55 Million	-3,296 Reduced 9.93%	29,881 $14 Million
Q1 2023 Apr 14, 2023	BUY	$310.63 - $364.82 $985,628 - $1.16 Million	3,173 Added 10.58%	33,177 $11.4 Million

Q4 2022 Feb 15, 2023	SELL	$321.55 - $374.67 $1.18 Million - $1.38 Million	-3,684 Reduced 10.94%	30,004 $11 Million
Q3 2022 Oct 27, 2022	BUY	$296.48 - $337.87 $7.17 Million - $8.18 Million	24,196 Added 254.91%	33,688 $10.9 Million
Q2 2022 Aug 01, 2022	SELL	$278.73 - $327.27 $1.19 Million - $1.4 Million	-4,284 Reduced 31.1%	9,492 $3.08 Million
Q1 2022 Apr 26, 2022	SELL	$234.69 - $291.66 $84,019 - $104,414	-358 Reduced 2.53%	13,776 $3.95 Million
Q4 2021 Feb 15, 2022	BUY	$224.85 - $279.04 $22,709 - $28,183	101 Added 0.72%	14,134 $3.9 Million
Q3 2021 Nov 16, 2021	SELL	$221.6 - $272.71 $1.4 Million - $1.73 Million	-6,332 Reduced 31.09%	14,033 $3.24 Million
Q2 2021 Jul 19, 2021	BUY	$180.55 - $233.54 $1.47 Million - $1.9 Million	8,150 Added 66.72%	20,365 $4.67 Million
Q1 2021 May 03, 2021	SELL	$164.32 - $212.72 $1.4 Million - $1.82 Million	-8,545 Reduced 41.16%	12,215 $2.28 Million
Q4 2020 Feb 09, 2021	SELL	$130.46 - $172.63 $24,135 - $31,936	-185 Reduced 0.88%	20,760 $3.51 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $190,086 - $219,869	1,300 Added 6.62%	20,945 $3.1 Million
Q2 2020 Jul 29, 2020	SELL	$136.42 - $164.18 $2.83 Million - $3.4 Million	-20,715 Reduced 51.33%	19,645 $3.23 Million
Q1 2020 Apr 30, 2020	BUY	$119.05 - $147.35 $2.19 Million - $2.7 Million	18,354 Added 83.4%	40,360 $5.6 Million
Q4 2019 Jan 29, 2020	SELL	$106.92 - $132.43 $3,956 - $4,899	-37 Reduced 0.17%	22,006 $2.89 Million
Q3 2019 Oct 29, 2019	SELL	$106.79 - $116.16 $6,834 - $7,434	-64 Reduced 0.29%	22,043 $2.47 Million
Q2 2019 Aug 19, 2019	BUY	$110.79 - $129.32 $2.45 Million - $2.86 Million	22,107 New	22,107 $2.45 Million
Q3 2018 Nov 08, 2018	SELL	$85.86 - $107.31 $732,214 - $915,139	-8,528 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$75.7 - $86.88 $645,569 - $740,912	8,528 New	8,528 $728,000

Others Institutions Holding LLY

# of Institutions

3,727

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $872B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chartwell Investment Partners, LLC with notifications on news.

Account

Chartwell Investment Partners, LLC Eli Lilly & CO Transaction History